Glenmark Pharma received US approval for its Fluticasone Propionate Nasal Spray, a generic equivalent to Flonase®. This boosts their US respiratory portfolio, targeting a market with $295.2 million in annual sales.

Glenmark Pharmaceuticals LimitedGLENMARK · Filed with the exchange

No comments yet. Be the first.

More from Glenmark Pharmaceuticals Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.